Editorial Standards

Latest News Today maintains rigorous editorial standards. Our team verifies information from trusted sources and provides context to help readers understand complex stories.

Last Updated: Thursday, October 1, 2026 at 07:56 PM
Category: Id

Editor's Note

Latest News Today provides comprehensive coverage and analysis of breaking news stories. This article is part of our ongoing coverage of wbna54978537, bringing you verified information from trusted sources with added context and expert perspective.

Why This Matters: Understanding the full context of this story helps readers make informed decisions and stay updated on developments that impact our community.

New Ragweed Allergy Pill Clears FDA

A new oral medication to treat ragweed allergies has been approved by the Food and Drug administration, the agency announced today (April 17).

A new oral medication to treat ragweed allergies has been approved by the Food and Drug administration, the agency announced today (April 17).

The medication, called Ragwitek (a drug from Merck and Co.), is a tablet taken once a day by placing it under the tongue, where it dissolves. It is approved for people who are allergic to pollen from the plant short ragweed (Ambrosia artemisiifolia).

Patients should start taking the medication 12 weeks before ragweed season, and use it throughout the season, the FDA said. The first dose should be taken in a doctor's office in case the patient has an allergic reaction to the drug, which contains extract from the short ragweed plant itself. [ 9 Weirdest Allergies ]

The drug is an alternative to allergy shots or medications that relieve allergy symptoms, the FDA said.

People with ragweed pollen allergies, one of the most common seasonal allergies, may have symptoms such as sneezing, a runny nose, nasal congestion, and itchy and watery eyes, especially during the late summer and early fall.

In a study of 1,700 adults, the most common side effects of the drug were itching and irritation in the mouth, ears and throat. During one allergy season, people who took Ragwitek had a 26 percent reduction in symptoms and the need for allergy medications compared with those who received a placebo, the FDA said.

Follow Rachael Rettner. FollowLive Science,&. Original article on